Join the Weight Loss (Obesity / Overweight) group to help and get support from people like you.
Weight Loss (Obesity / Overweight) News (Page 2)
Related terms: Weight Gain, Overweight, Weightloss, Anorexiants, Obesity, Obese, Weight Loss, Loose Weight, Lost Weight, diet drugs, diet medications, anti-obesity medications, Weight Loss Medications
Monthly Obesity Shot, MariTide, Shows Big Weight Loss in Trial
WEDNESDAY, June 25, 2025 — Alternatives to weekly injections of weight-loss drugs may on the way. A monthly dose of a new drug called MariTide helped participants in a phase 2 clinical trial shed a...
Rival GLP-1 Weight-Loss Drug, Ecnoglutide, Emerges From China
TUESDAY, June 24, 2025 — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic/Wegovy and Zepbound, clinical trial results show. Ecnoglutide helped p...
Studies Address Muscle Loss Caused By GLP-1 Drugs, such as Ozempic and Zepbound
TUESDAY, June 24, 2025 — GLP-1 drugs like Ozempic and Zepbound are great at promoting weight loss, but they also cause folks to lose muscle along with fat. Experts are now turning their attention t...
Weighted Vests Don't Protect Bone Health In Dieting Seniors, Trial Says
TUESDAY, June 24, 2025 — Weighted vests have been touted as a potential means of warding off osteoporosis while losing weight. The idea is that the extra weight will promote new bone growth even as p...
Self-Esteem Scores Soar One Year After Metabolic, Bariatric Surgery
TUESDAY, June 24, 2025 – Self-esteem scores increase after metabolic and bariatric surgery (MBS), with greater improvement in scores for those with higher postoperative weight loss, according to a...
Trading Diet Sodas For Water Can Help Control Diabetes And Lose Weight
MONDAY, June 23, 2025 — Want to lose weight and reverse type 2 diabetes? Trade your diet soda for a tall glass of water, a new small-scale study argues. Women were more likely to drop pounds and see t...
ADA: Ecnoglutide Yields Superior, Sustained Reduction in Body Weight
MONDAY, June 23, 2025 – For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon like peptide 1 receptor agonist, ecnoglutide, yields a...
Minor Complications Up for Black Patients After Weight-Loss Surgery
MONDAY, June 23, 2025 – Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a study presented at the annual meeting of the American...
Dementia Caregivers Have Modifiable Risk Factors Increasing Their Own Risk
FRIDAY, June 20, 2025 – Six in 10 dementia caregivers report having at least one modifiable risk factor that could increase their own chances of developing dementia, according to a report issued...
Semaglutide Offers Cardiovascular Edge Over Empagliflozin in Type 2 Diabetes
FRIDAY, June 20, 2025 – For patients aged 45 years or older with type 2 diabetes, semaglutide seems to confer some advantage over empagliflozin in terms of mortality and cardiovascular event risks,...
Likelihood of Psych Disorders Lower With Weight-Loss Surgery Versus GLP-1 RAs
FRIDAY, June 20, 2025 – People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated with glucagon-like peptide-1 receptor agonists...
Metabolic Dysfunction-Associated Steatotic Liver Disease Linked to Risk for Sudden Hearing Loss
FRIDAY, June 20, 2025 – Among older adults, metabolic dysfunction-associated steatotic liver disease (MASLD) is associated with increased risk for sudden sensorineural hearing loss (SSNHL),...
Waist-to-Height Ratio Predicts Liver Steatosis and Fibrosis
WEDNESDAY, June 18, 2025 – Waist-to-height ratio (WHtR) outperforms body mass index (BMI) in detecting the risk for liver disease, according to a study published in the July issue of the Journal of ...
Few Adolescents With Obesity Prescribed Obesity Medications
FRIDAY, June 13, 2025 – Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023, according to research...
Most People Open To Sharing Smartwatch Health Data With Doctors
THURSDAY, June 12, 2025 — A person’s smartwatch can capture a lot of data about their health – and a new study says most folks are willing to share it with doctors. About 94% of people who wear smart...
Further information
Related drug support groups
bupropion, phentermine, Contrave, Ozempic, amphetamine, Saxenda, methamphetamine, Mounjaro, topiramate, view more... Wegovy, semaglutide, methylphenidate, Qsymia, Zepbound, liraglutide, tirzepatide, Adipex-P, Alli, orlistat, dulaglutide, garcinia cambogia, desvenlafaxine